NCT05642598 is a NA clinical trial of Pivot for Vape in Vaping Cessation, sponsored by Pivot Health Technologies Inc..

Who is sponsoring NCT05642598?

NCT05642598 is sponsored by Pivot Health Technologies Inc..

What drugs are being tested in NCT05642598?

Interventions in NCT05642598: Pivot for Vape.

What condition does NCT05642598 study?

NCT05642598 studies Vaping Cessation.

Is NCT05642598 still recruiting?

NCT05642598 is currently completed. Last updated 31 January 2025.

Last reviewed 2025-01-31 · How we verify

NCT05642598

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study of a Smartphone-Based Vaping Cessation Program

Completed NA Last updated 31 January 2025

What this trial tests

NA trial testing Pivot for Vape in Vaping Cessation in 73 participants. Completed in 23 May 2024.

Timeline

7 February 2023

Primary endpoint
23 May 2024

23 May 2024

Quick facts

Lead sponsor	Pivot Health Technologies Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	73
Start date	7 February 2023
Primary completion	23 May 2024
Estimated completion	23 May 2024
Sites	1 location across United States

Drugs / interventions tested

Pivot for Vape

Conditions studied

Vaping Cessation — all drugs for Vaping Cessation →

Sponsor

Pivot Health Technologies Inc.

Who can join

21 and older, any sex, with Vaping Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, open label, single center clinical study enrolling up to 100 participants to evaluate the effect of the Pivot vaping cessation program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Outcomes of a Comprehensive Mobile Vaping Cessation Program in Adults Who Vape Daily: Cohort Study.
Marler JD, Fujii CA, Utley MT, Balbierz DJ, et al · · 2024 · cited 1× · PMID 39331522 · DOI 10.2196/57376

Verify or expand the search:

Other recruiting trials for Vaping Cessation

Currently open trials in the same condition.

NCT06832098 — Nicotine Patch Plus Nicotine Mouth Spray Versus Nicotine Reduction for Vaping Cessation · Phase 3 · recruiting
NCT07192601 — Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study · NA · active not recruiting
NCT05967585 — Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics · NA · recruiting

Other Pivot Health Technologies Inc. trials

Trials by the same sponsor.

NCT06544772 — Study of a Smartphone-Based Switch Program · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05642598 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pivot Health Technologies Inc.
Last refreshed: 31 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05642598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing